| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 13, 2026 | Violet Therapeutics Raises $4.75M Seed Extension to Advance Novel Therapeutic for Synaptic Preservation and Repair | CAMBRIDGE, MA, UNITED STATES, May 13, 2026 /EINPresswire.com/ -- Violet Therapeutics (“Violet”), a biotechnology company developing first-in-class therapies for neurodegenerative diseases, today announced the closing of a $4.75M seed extens... |
| Jun 16, 2023 | Ono Venture Investment Invests in Violet Therapeutics.
(Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV)) | |
| Jun 2, 2023 | Violet Therapeutics Raises $10.6M in Seed Funding | Violet Therapeutics, a Cambridge, MA-based therapeutics company utilizing proprietary platforms for the identification of cell-cell interaction mechanisms, raised $10.6M in Seed funding.
The round was led by Dementia Discovery Fund (DDF), U... |
| May 31, 2023 | Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV) | |
| May 31, 2023 | Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV) | /EIN News/ --
Round led by the DDF (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and founding investor Mass General Brigham Ventures (MGBV), and joined by Ono Venture Investment
Cambridge, MA – May 31st, 202... |
| May 31, 2023 | Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV) | Round led by the DDF (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and founding investor Mass General Brigham Ventures (MGBV), and joined by Ono Venture Investment |
| Violet Therapeutics | “Coming Soon” |
